Plasma Fractionation Market 2025–2029: Strategic Opportunities and Growth Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the plasma fractionation market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Plasma Fractionation Market Now And By 2029?

The plasma fractionation market has observed substantial growth over recent years. Its size is projected to expand from $31.42 billion in 2024 to $34.14 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.6%. This historical growth can be linked to the increasing prevalence of hemophilia and immunodeficiency disorders, a growing aging population, the escalating demand for immunoglobulins, the expansion of plasma collection centers, and a rising number of surgical procedures.

The plasma fractionation market size is projected to experience substantial expansion over the upcoming years, reaching $50.54 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.3%. This anticipated growth during the forecast period is driven by factors such as increasing worldwide healthcare spending, expanding uses of medicinal products derived from plasma, greater investment in research and development, the need for plasma in managing neurological conditions, and the growth of plasma fractionation facilities. Key trends foreseen in this period involve the creation of novel fractionation technologies, a move towards treatments utilizing albumin and immunoglobulin, increasing demand for specialized plasma products, an emphasis on technologies for inactivating pathogens, and strategic alliances and partnerships within the plasma sector.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

Which Long-Term Drivers Are Expected To Sustain The Plasma Fractionation Market?

A growing incidence of chronic conditions is anticipated to drive the expansion of the plasma fractionation market in the future. These are ailments lasting a minimum of one year and demanding continuous medical care, encompassing examples like heart disease, cancer, and diabetes. Providing chronic disease patients with plasma products leads to reduced illness, enhanced life quality, and cost efficiency, consequently boosting the demand for plasma fractionation. As an illustration, a January 2023 report from the National Library of Medicine, a US-based organization, indicated that the population aged 50 and above suffering from one or more chronic conditions is forecast to increase by 99.5%, climbing from 71.522 million in 2020 to 142.66 million by 2050 in the United States. Consequently, the rising occurrence of chronic diseases is fueling the expansion of the healthcare analytical testing service market. Thus, a growing prevalence of chronic diseases across all age groups is poised to further stimulate the plasma fractionation market growth.

How Is The Plasma Fractionation Market Classified By Different Segments?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

What Current And Upcoming Trends Are Shaping The Plasma Fractionation Market?

Key companies in the market are implementing new technologies, such as advanced facility processes that transform donated human plasma into essential medicines, employing sophisticated methods to enhance efficiency and safety. For example, in March 2023, CSL Behring, a German-based company, launched a new $470 million plasma fractionation facility. This facility utilizes cutting-edge technology to improve the efficiency and safety of plasma processing, thereby ensuring higher quality and more reliable medicines. By boosting the supply of these critical treatments, the facility helps address the rising demand, guaranteeing more patients receive access to life-saving therapies. Its advanced automation and self-cleaning systems also reduce the risk of contamination and improve overall hygienic standards, significantly enhancing patient safety.

Who Are The Primary Market Leaders In The Plasma Fractionation Market?

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Plasma Fractionation Market?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

Browse Through More Reports Similar to the Global Plasma Fractionation Market 2025, By The Business Research Company

Blood And Blood Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Convalescent Plasma Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Patient Blood Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795